Metastatic inflammatory breast cancer: Clinical features and outcomes in the national, multicentric, real-life ESME cohort

被引：0

作者：

Monneur, A.

Bertucci, F.

Lardy-Cleaud, A.

Augereau, P.

Debled, M.

Levy, C.

Mouret-Reynier, M. A.

Coudert, B.

Mailliez, A.

Bachelot, T.

Ferrero, J-M

Guiu, S.

Uwer, L.

Campone, M.

Cottu, P.

Jouannaud, C.

Rouge, T. De la Motte

Leheurteur, M.

Petit, T.

Pistilli, B.

Dalenc, F.

Simon, G.

Robain, M.

Viens, P.

Lerebours, F.

Goncalves, A.

机构：

[1] Inst Paoli Calmettes, Marseille, France

[2] Ctr Leon Berard, Biometr Unit, Lyon, France

[3] Inst Cancerol Ouest, Angers, France

[4] Inst Bergonie, Bordeaux, France

[5] Ctr Francois Baclesse, Caen, France

[6] Ctr Jean Perrin, Clermont Ferrand, France

[7] Ctr Georges Francois Leclerc, Dijon, France

[8] Ctr Oscar Lambret, Lille, France

[9] Ctr Leon Berard, Lyon, France

[10] Ctr Antoine Lacassagne, Nice, France

[11] Inst Canc Montpellier, Montpellier, France

[12] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France

[13] Inst Cancerol Ouest, St Herblain, France

[14] Inst Curie, Paris, France

[15] Inst Curie, St Cloud, France

[16] Inst Cancerol Jean Godinot, Reims, France

[17] Ctr Eugene Marquis, Rennes, France

[18] Ctr Henri Becquerel, Rouen, France

[19] Ctr Paul Strauss, Strasbourg, France

[20] Inst Gustave Roussy, Villejuif, France

[21] Inst Claudius Regaud IUCT Oncopole, Toulouse, France

[22] Unicancer, Paris, France

来源：

CANCER RESEARCH | 2019年 / 79卷 / 04期

关键词：

D O I：

10.1158/1538-7445.SABCS18-P5-17-04

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P5-17-04

引用

页数：3

共 50 条

[31] Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
Holvoet, Tom
Truyens, Marie
De Galan, Cara
Peeters, Harald
Gismero, Francisco Mesonero
Elorza, Ainara
Torres, Paola
Vandermeulen, Liv
Jauregui-Amezaga, Aranzazu
Ferreiro-Iglesias, Rocio
Zabana, Yamile
Reverter, Laia Peries
Geldof, Jeroen
Lobaton, Triana
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
[32] Treatment and outcomes of older versus younger women with HER2 positive metastatic breast cancer in the real-world national ESME database
Annonay, Mylene
Gauquelin, Lisa
Geiss, Romain
Ung, Mony
Cristol-Dalstein, Laurence
Mouret-Reynier, Marie-Ange
Goncalves, Anthony
Abadie-Lacourtoisie, Sophie
Francois, Eric
Perrin, Christophe
Le Fel, Johan
Lorgis, Veronique
Servent, Veronique
Uwer, Lionel
Jouannaud, Christelle
Leheurteur, Marianne
Joly, Florence
Campion, Loic
Courtinard, Coralie
Villacroux, Olivier
Petit, Thierry
Soubeyran, Pierre
Terret, Catherine
Bellera, Carine
Brain, Etienne
Delaloge, Suzette
BREAST, 2021, 60 : 138 - 146
[33] Phenotypic discordance between primary and metastatic breast cancer (MBC) in a large scale real-life multicentre French cohort
Lefevre, S.
Lusque, A.
Joyon, N.
Arnould, L.
Penault-Llorca, F.
MacGrogan, G.
Treilleux, I.
Vincent-Salomon, A.
Haudebourg, J.
Maran-Gonzalez, A.
Charafe-Jauffret, E.
Courtinard, C.
Franchet, C.
Verriele, V.
Brain, E.
Tas, P.
Delaloge, S.
Filleron, T.
LaCroix-Triki, M.
CANCER RESEARCH, 2019, 79 (04)
[34] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat
Denis Smith
Magali Rouyer
Jacques Bénichou
Rosine Guimbaud
Yves Bécouarn
Olivier Bernard
Pernelle Noize
Nicholas Moore
Alain Ravaud
Targeted Oncology, 2014, 9 : 311 - 319
[35] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Fourrier-Reglat, Annie
Smith, Denis
Rouyer, Magali
Benichou, Jacques
Guimbaud, Rosine
Becouarn, Yves
Bernard, Olivier
Noize, Pernelle
Moore, Nicholas
Ravaud, Alain
TARGETED ONCOLOGY, 2014, 9 (04) : 311 - 319
[36] Management and outcome of metastatic breast cancer in men in the national multicenter observational ESME program
Sirieix, J.
Fraisse, J.
Mathoulin-Pelissier, S.
Leheurteur, M.
Vanlemmens, L.
Jouannaud, C.
Dieras, V.
Levy, C.
Dalenc, F.
Mouret-Reynier, M-A.
Petit, T.
Coudert, B.
Brain, E.
Pistilli, B.
Ferrero, J-M.
Goncalves, A.
Uwer, L.
Gourgou, S.
Frenel, J-S.
ANNALS OF ONCOLOGY, 2018, 29
[37] From clinical trials to clinical practice: Real-life outcome data of everolimus and exemestane in the treatment of patients with metastatic breast cancer
Abdel-Razeq, Hikmat
Sharaf, Baha'
Abdulelah, Hazem
Inserat, Bayan
Al-Tell, Abdallah
Salam, Mourad
Bater, Rayan
CANCER RESEARCH, 2021, 81 (04)
[38] Hypofractionated external beam radiation therapy for breast cancer: real-life outcomes
Correia, D.
Fernandes, B.
Ponte, A.
Marques, M.
Couto-Goncalves, S.
Rolim, L.
Nobre-Gois, I.
Carvalho, C.
Casalta-Lopes, J.
Borrego, M.
RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S521 - S521
[39] Response to Erythropoietin in a Multicentric Real-Life Cohort of Myelodysplastic Patients: The Grom Experience
Latagliata, Roberto
Spiriti, Maria Antonietta Aloe
Maurillo, Luca
Nobile, Carolina
Piccioni, Anna Lina
Criscuolo, Marianna
Naso, Virginia
Spadea, Antonio
Niscola, Pasquale
Tatarelli, Caterina
Neri, Benedetta
Villiva, Nicoletta
Vozella, Federico
D'Andrea, Mariella
Battistini, Roberta
Fenu, Susanna
Breccia, Massimo
Mancini, Stefano
Voso, Maria Teresa
Buccisano, Francesco
BLOOD, 2012, 120 (21)
[40] Prediction of PFS and OS under third and fourth line chemotherapy among metastatic triple-negative breast cancer patients in the national multicenter ESME metastatic breast cancer cohort
Cabel, Luc
Carton, Matthieu
Pistilli, Barbare
Dalenc, Florence
Vanlemnens, Laurence
Levy, Christelle
Jacot, William
Debled, Marc
Loeb, Agnes
Coudert, Bruno
Rouge, Thubault De la Motte
Laborde, Lilian
Laurent, Carine
Chamorey, Emmanuel
Parent, Damien
Petit, Thierry
Mouret-Reynier, Marie-Ange
Perrocheau, Genevieve
Labreveux, Claire
Bachelot, Thomas
Robain, Mathieu
Lerebours, Florence
CANCER RESEARCH, 2020, 80 (04)

← 1 2 3 4 5 →